+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioprosthetics Market Analysis By Product Type, By Application, By Region, Forecasts to 2026

  • PDF Icon


  • 150 Pages
  • August 2020
  • Region: Global
  • Reports and Data
  • ID: 5317677
Increasing prevalence of rheumatoid heart disease, coronary and peripheral artery diseases, and other cardiovascular diseases have led to increasing need and demand for long-term treatment such as bioprosthetics, which is a key factor driving market revenue growth.

Market Size - USD 4,122.6 Million in 2020, Market Growth - CAGR of 9.8%, Market Trends - Constant technological advancements such as development of hybrid tissue-engineered bioprostheses.

The global bioprosthetics market size is expected to reach USD 8,794.8 Million in 2028, and register a CAGR of 9.8% during the forecast period. Growing geriatric population, coupled with rising prevalence of age-associated heart diseases such as degenerative cardiac diseases are some of the major factors expected to augment market growth during the forecast period.

Bioprosthetics effectively reduce morbidity associated with cardiac valve disorders, thus becoming ideal option for patients with heart diseases and highly preferred among healthcare professionals. Additionally, advanced tissue treatment processes further enhance the strength of the prostheses and eliminate the need for long-term medication. These are other major factors expected to drive growth of the global bioprosthetics market during the forecast period.

Some Key Findings From the Report:
  • Among the application segments, the cardiovascular valves segment accounted for the largest revenue share of 89.2% in 2020.
  • Europe market accounted for the largest revenue share in the global market in 2020, due to highly evolved and technologically advanced healthcare sector, and extensive research funding by government in countries in the region.
  • The Asia Pacific market was valued at USD 907.0 Million in 2020, and is expected to register a robust revenue growth rate during the forecast period, due to growing number of collaborations between the international players involved in bioprosthetics, and government in countries in the region is, which in turn, is gradually enhancing access to healthcare facilities.
  • Key players profiled in the report include Sorin Group, CryoLife, Inc., Medtronic Plc, Braile Biomedica, Ethicon, Inc., Life Cell Corporation, Organogenesis, Inc., Labcor Laboratories Ltd., Maquet Metinge Group, and JenaValve Technology GmbH. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.

For the purpose of this report, the global bioprosthetics market is segmented on the basis of product type, application, and region:

Product Type Outlook
  • Allograft
  • Xenograft
  • Stented
  • Stentless
  • Sututreless
  • Porcine
  • Bovine

Application Outlook
  • Cardiovascular Valves
  • Allograft
  • Xenograft
  • Transcatheter heart valves
  • Plastic surgery & wound healing

Region Outlook
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Reasons to Buy the Report
  • A robust analysis and estimation of the Bioprosthetics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in Bioprosthetics Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization

Table of Contents

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 - 2026
Chapter 3. Indicative Metrics
3.1. Rising population and awareness globally.
3.2. Increasing incidences of allergic contact dermatitis
3.3. Global burden of obesity and modern unhealthy lifestyle related problems
3.4. Rise of standard of living and increase in disposable income enabling people to opt for Bioprosthetics procedures.
Chapter 4. Bioprosthetics Segmentation & Impact Analysis
4.1. Bioprosthetics Segmentation Analysis
4.2. Bioprosthetics Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Bioprosthetics Market Impact Analysis
4.5. Key opportunities prioritized
4.6. Bioprosthetics Pricing Analysis
Chapter 5. Bioprosthetics Market By Type Insights & Trends
5.1. Bioprosthetics Type dynamics & Market Share, 2018 & 2026
5.2. Allograft
5.3. Xenograft
5.4. Porcine
5.5. Bovine
Chapter 6. Bioprosthetics Market by Application Type Insights & Trends
6.1. Bioprosthetics Disease Type dynamics & Market Share, 2018 & 2026
6.2. Cardiovascular
Chapter 7. Bioprosthetics Market Regional Outlook
7.1. Bioprosthetics Market share by region, 2018 & 2026
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Middle East & Africa
7.6. Latin America
Chapter 8. Competitive Landscape
8.1. Market Revenue Share by Manufacturers
8.2. Manufacturing Cost Breakdown Analysis
8.3. Mergers & Acquisitions
8.4. Strategy Benchmarking
8.5. Vendor Landscape
Chapter 9. Company Profiles
9.1. Sorin Group
9.2. CryoLife, Inc.
9.3. Medtronic Plc
9.4. Braile Biomedica
9.5. Ethicon, Inc.
9.6. GlaxoSmithKline
9.7. Life Cell Corporation
9.8. Organogenesis Inc.
9.9. Labcor Laboratorios Ltd.
9.10. Maquet Metinge Group
9.11. JenaValve Technology GmbH

Companies Mentioned

  • Sorin Group
  • CryoLife Inc
  • Medtronic Plc
  • Braile Biomedica
  • Ethicon Inc
  • Life Cell Corporation
  • Organogenesis Inc
  • Labcor Laboratories Ltd
  • Maquet Metinge Group
  • JenaValve Technology GmbH